Immunotherapy has saved countless lives, but only 20 to 25 percent of patients respond to this treatment that activates a person's own immune system to attack their cancer. Predicting who would benefit from this approach and why could help patients who have exhausted other options, such as chemo...
daily, according to the American Cancer Society. The good news is that Medicare does cover cancer treatment. If you have a Part D prescription drug plan and a comprehensive Medigap plan, most of your treatment has 100% coverage. Here are the facts on Medicare coverage for cancer treatments....
The immune system's T cells play a key role in fighting cancer. When a T cell recognizes a cancer cell as foreign, through a receptor on its surface, it targets the cancer cell for destruction. Scientists have discovered how to alter receptor proteins on T cells—often done by adding DNA...
Statistically, the odds for a good response were pitiful, but so were the odds for my getting kidney cancer in the first place. The “Why me?”s became “Why not me? Someone has to be in the 7%!”. I talked to a patient who had gone through the treatment. She described it as “...
Researchers at the Spanish National Cancer Research Center (CNIO) propose a new treatment for brain metastases that respond poorly, or not at all, to immunotherapy, and provide a biomarker to predict in which cases it should ...
More information:Jiyan Wang et al, The dysfunctional Wnt pathway down-regulates MLH1/SET expression and promotes microsatellite instability and immunotherapy response in colorectal cancer,Genes & Diseases(2023).DOI: 10.1016/j.gendis.2023.03.026
prompting an attack on tumors by the immune system's killer Tcells. Although these therapies have notched up successes against some major cancers—most notablymelanomaandlung cancer—they fail to induce responses in many patients. For example, more than 40% of melanoma patients fail to benefit fr...